Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.53 billion. The enterprise value is $1.71 billion.
| Market Cap | 1.53B |
| Enterprise Value | 1.71B |
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 50.12 million shares outstanding. The number of shares has increased by 2.20% in one year.
| Current Share Class | 50.12M |
| Shares Outstanding | 50.12M |
| Shares Change (YoY) | +2.20% |
| Shares Change (QoQ) | -3.91% |
| Owned by Insiders (%) | 12.85% |
| Owned by Institutions (%) | 52.30% |
| Float | 37.55M |
Valuation Ratios
The trailing PE ratio is 33.93 and the forward PE ratio is 23.67. Astrana Health's PEG ratio is 3.37.
| PE Ratio | 33.93 |
| Forward PE | 23.67 |
| PS Ratio | 0.71 |
| Forward PS | 0.54 |
| PB Ratio | 2.05 |
| P/TBV Ratio | 8.73 |
| P/FCF Ratio | 34.66 |
| P/OCF Ratio | 29.32 |
| PEG Ratio | 3.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.59, with an EV/FCF ratio of 38.75.
| EV / Earnings | 39.67 |
| EV / Sales | 0.84 |
| EV / EBITDA | 14.59 |
| EV / EBIT | 19.16 |
| EV / FCF | 38.75 |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.92.
| Current Ratio | 1.75 |
| Quick Ratio | 1.68 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | 3.64 |
| Debt / FCF | 10.68 |
| Interest Coverage | 2.70 |
Financial Efficiency
Return on equity (ROE) is 10.80% and return on invested capital (ROIC) is 6.50%.
| Return on Equity (ROE) | 10.80% |
| Return on Assets (ROA) | 4.88% |
| Return on Invested Capital (ROIC) | 6.50% |
| Return on Capital Employed (ROCE) | 9.03% |
| Revenue Per Employee | $1.07M |
| Profits Per Employee | $22,710 |
| Employee Count | 1,900 |
| Asset Turnover | 1.78 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $30.89 million in taxes.
| Income Tax | 30.89M |
| Effective Tax Rate | 38.22% |
Stock Price Statistics
The stock price has decreased by -25.73% in the last 52 weeks. The beta is 1.30, so Astrana Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | -25.73% |
| 50-Day Moving Average | 33.74 |
| 200-Day Moving Average | 43.38 |
| Relative Strength Index (RSI) | 45.84 |
| Average Volume (20 Days) | 367,308 |
Short Selling Information
The latest short interest is 1.87 million, so 3.72% of the outstanding shares have been sold short.
| Short Interest | 1.87M |
| Short Previous Month | 1.68M |
| Short % of Shares Out | 3.72% |
| Short % of Float | 4.97% |
| Short Ratio (days to cover) | 3.75 |
Income Statement
In the last 12 months, Astrana Health had revenue of $2.03 billion and earned $43.15 million in profits. Earnings per share was $0.90.
| Revenue | 2.03B |
| Gross Profit | 271.39M |
| Operating Income | 89.35M |
| Pretax Income | 96.65M |
| Net Income | 43.15M |
| EBITDA | 117.28M |
| EBIT | 89.35M |
| Earnings Per Share (EPS) | $0.90 |
Balance Sheet
The company has $290.85 million in cash and $471.84 million in debt, giving a net cash position of -$180.99 million or -$3.61 per share.
| Cash & Cash Equivalents | 290.85M |
| Total Debt | 471.84M |
| Net Cash | -180.99M |
| Net Cash Per Share | -$3.61 |
| Equity (Book Value) | 514.17M |
| Book Value Per Share | 14.87 |
| Working Capital | 272.89M |
Cash Flow
In the last 12 months, operating cash flow was $52.20 million and capital expenditures -$8.03 million, giving a free cash flow of $44.17 million.
| Operating Cash Flow | 52.20M |
| Capital Expenditures | -8.03M |
| Free Cash Flow | 44.17M |
| FCF Per Share | $0.88 |
Margins
Gross margin is 13.34%, with operating and profit margins of 4.39% and 2.12%.
| Gross Margin | 13.34% |
| Operating Margin | 4.39% |
| Pretax Margin | 3.97% |
| Profit Margin | 2.12% |
| EBITDA Margin | 5.76% |
| EBIT Margin | 4.39% |
| FCF Margin | 2.17% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.20% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.82% |
| FCF Yield | 2.89% |
Analyst Forecast
The average price target for Astrana Health is $56.17, which is 83.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56.17 |
| Price Target Difference | 83.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 3.76 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.76 |
| Piotroski F-Score | 5 |